Histamine, a vasoactive agent with vascular disrupting potential, improves tumour response by enhancing local drug delivery

Tumour necrosis factor (TNF)-based isolated limb perfusion (ILP) is an approved and registered treatment for sarcomas confined to the limbs in Europe since 1998, with limb salvage indexes of 76%. TNF improves drug distribution in solid tumours and secondarily destroys the tumour-associated vasculatu...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunstein, F, Rens, J, van Tiel, S T, Eggermont, A M M, ten Hagen, T L M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360755/
https://www.ncbi.nlm.nih.gov/pubmed/17106443
http://dx.doi.org/10.1038/sj.bjc.6603461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360755/
https://www.ncbi.nlm.nih.gov/pubmed/17106443
http://dx.doi.org/10.1038/sj.bjc.6603461

Ejemplares similares